Ilser Turkyilmaz1. 1. Department of Prosthodontics, Dental School, University of Texas Health Science Center, San Antonio, TX, USA. turkyilmaz@uthscsa.edu
Abstract
PURPOSE: Diabetes mellitus is a prevalent medical disorder. It is often accompanied with systemic adverse sequelae, such as wound healing alterations, which may affect osseointegration of dental implants. The use of dental implants in patients with diabetes mellitus remains controversial because altered bone healing around implants has been reported. The purpose of this study was to present 1-year clinical outcomes of 23 implants placed in 10 patients with well-, or moderately well, controlled type 2 diabetes mellitus. MATERIALS: All implants were uneventfully placed in the mandible or maxilla. Three different types of definitive implant-supported prostheses, cement- or screw-retained fixed dental prostheses, and overdentures were delivered to the patients. RESULTS: At 1-year follow-up recall, no implants were lost, and 0.3 +/- 0.2 mm marginal bone loss was noted. No periapical radiolucencies, no bleeding on probing, or pathologic probing depth were recorded at these recalls. CONCLUSION: This clinical report supports the use of dental implants in patients with well-, or moderately well, controlled type 2 diabetes mellitus as a dental treatment modality. No evidence of diminished clinical success or significant complication related to implant treatment was found for this patient population.
PURPOSE:Diabetes mellitus is a prevalent medical disorder. It is often accompanied with systemic adverse sequelae, such as wound healing alterations, which may affect osseointegration of dental implants. The use of dental implants in patients with diabetes mellitus remains controversial because altered bone healing around implants has been reported. The purpose of this study was to present 1-year clinical outcomes of 23 implants placed in 10 patients with well-, or moderately well, controlled type 2 diabetes mellitus. MATERIALS: All implants were uneventfully placed in the mandible or maxilla. Three different types of definitive implant-supported prostheses, cement- or screw-retained fixed dental prostheses, and overdentures were delivered to the patients. RESULTS: At 1-year follow-up recall, no implants were lost, and 0.3 +/- 0.2 mm marginal bone loss was noted. No periapical radiolucencies, no bleeding on probing, or pathologic probing depth were recorded at these recalls. CONCLUSION: This clinical report supports the use of dental implants in patients with well-, or moderately well, controlled type 2 diabetes mellitus as a dental treatment modality. No evidence of diminished clinical success or significant complication related to implant treatment was found for this patient population.
Authors: David A Albert; Angela Ward; Pamela Allweiss; Dana T Graves; William C Knowler; Carol Kunzel; Rudolph L Leibel; Karen F Novak; Thomas W Oates; Panos N Papapanou; Ann Marie Schmidt; George W Taylor; Ira B Lamster; Evanthia Lalla Journal: Ann N Y Acad Sci Date: 2012-03-12 Impact factor: 5.691
Authors: Thomas W Oates; Patrick Galloway; Peggy Alexander; Adriana Vargas Green; Guy Huynh-Ba; Jocelyn Feine; C Alex McMahan Journal: J Am Dent Assoc Date: 2014-12 Impact factor: 3.634